[WS(P)29] Cell therapy, vaccine, and new therapeutic modality

[WS29-15-P] A combination of systemic plus intra-tumor neopeptide vaccination controls tumors in a mouse model

^○Kou Hioki¹, Melisa D. Castro Eiro¹, Ling Li¹, Marlous Wildemans¹, Youkyung Lim¹, Harmen J. G. van de Werken¹, Yvonne M. Mueller¹, Burcu Temizoz², Kouji Kobiyama², Christopher Schliehe¹, Ken J. Ishii², Peter D. Katsikis¹ (1.Department of Immunology; Erasmus University Medical Center, Rotterdam, the Netherlands, 2.Division of Vaccine Science, Department of Microbiology and Immunology, International Vaccine Design Center (vDesC), The Institute of Medical Science, The University of Tokyo (IMSUT), Tokyo, Japan)

キーワード：

Neopeptide vaccine、Adjuvants、Neopeptides、Intra-tumor vaccination

閲覧にはパスワードが必要です

ログイン

または